期刊
TRENDS IN IMMUNOLOGY
卷 43, 期 3, 页码 170-172出版社
CELL PRESS
DOI: 10.1016/j.it.2022.01.009
关键词
-
类别
资金
- National Natural Science of China [82041025]
The simultaneous presence of SARS-CoV-2 and MERS-CoV raises concerns about the potential emergence of new beta-coronavirus strains with high transmissibility similar to SARS-CoV-2 and high mortality rates similar to MERS-CoV. Therefore, there is an urgent need to develop pan-beta-CoV vaccines capable of targeting not only current variants of concern, but also potential future coronaviruses resembling SARS-CoV-3 or MERSCoV-2.
The concurrent prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Middle East respiratory syndrome coronavirus (MERS-CoV) raises the concern for the emergence of potential new beta-CoV clades via genetic recombination, bearing high SARS-CoV-2-like transmissibility and high MERS-CoV-like mortality rates. Therefore, we argue that there is an urgent need to develop pan-beta-CoV vaccines that can target not only current SARS-CoV-2 variants of concern, but also future putative SARS-CoV-3-or MERSCoV-2-like coronavirus.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据